Renalytix Plc Share Price BOERSE MUENCHEN
Equities
2O9
GB00BYWL4Y04
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.238 EUR | +40.00% | +40.83% | +22.05% |
14/06 | Renalytix's Diabetes, Kidney Disease Test Gets Medicare Final Coverage Determination | MT |
14/06 | Renalytix Secures Medicare's Final Local Coverage Determination for Kidney Disease Test | MT |
Sales 2024 * | 2.5M 2.34M 209M | Sales 2025 * | 9.6M 8.97M 802M | Capitalization | 37.69M 35.21M 3.15B |
---|---|---|---|---|---|
Net income 2024 * | -33M -30.83M -2.76B | Net income 2025 * | -26M -24.29M -2.17B | EV / Sales 2024 * | 15.1 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 3.93 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 61.53% |
Latest transcript on Renalytix Plc
1 week | +40.83% | ||
Current month | +50.63% | ||
1 month | -22.73% | ||
3 months | -32.39% | ||
6 months | +14.42% | ||
Current year | +22.05% |
Managers | Title | Age | Since |
---|---|---|---|
James McCullough
FOU | Founder | 56 | 15/18/15 |
Howard Doran
PSD | President | 63 | 01/23/01 |
Fergus Fleming
CTO | Chief Tech/Sci/R&D Officer | 57 | 15/18/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Levangie
BRD | Director/Board Member | 73 | 30/21/30 |
Chairman | 72 | 15/18/15 | |
James McCullough
FOU | Founder | 56 | 15/18/15 |
Date | Price | Change |
---|---|---|
14/24/14 | 0.238 | +40.00% |
13/24/13 | 0.17 | 0.00% |
12/24/12 | 0.17 | 0.00% |
11/24/11 | 0.17 | 0.00% |
10/24/10 | 0.17 | +0.59% |
Real-time BOERSE MUENCHEN, June 15, 2024 at 01:13 am IST
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.26% | 16.26B | |
-50.54% | 2.44B | |
+25.26% | 1.98B | |
-8.81% | 1.52B | |
+28.12% | 1.3B | |
-18.54% | 937M | |
-32.14% | 775M | |
-1.69% | 760M | |
-26.54% | 615M |
- Stock Market
- Equities
- RENX Stock
- 2O9 Stock